ACLX
Price
$86.68
Change
+$0.24 (+0.28%)
Updated
Nov 5, 04:48 PM (EDT)
6 days until earnings call
BEAM
Price
$23.89
Change
-$0.47 (-1.93%)
Updated
Nov 5, 04:55 PM (EDT)
Earnings call today
Ad is loading...

ACLX vs BEAM

Header iconACLX vs BEAM Comparison
Open Charts ACLX vs BEAMBanner chart's image
Arcellx
Price$86.68
Change+$0.24 (+0.28%)
Volume$6.74K
CapitalizationN/A
Beam Therapeutics
Price$23.89
Change-$0.47 (-1.93%)
Volume$21.35K
CapitalizationN/A
View a ticker or compare two or three
ACLX vs BEAM Comparison Chart
Loading...
ACLX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
BEAM
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
ACLX vs. BEAM commentary
Nov 05, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACLX is a Hold and BEAM is a Hold.

COMPARISON
Comparison
Nov 05, 2024
Stock price -- (ACLX: $86.44 vs. BEAM: $24.36)
Brand notoriety: ACLX and BEAM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACLX: 141% vs. BEAM: 139%
Market capitalization -- ACLX: $4.65B vs. BEAM: $2.01B
ACLX [@Biotechnology] is valued at $4.65B. BEAM’s [@Biotechnology] market capitalization is $2.01B. The market cap for tickers in the [@Biotechnology] industry ranges from $498.83B to $0. The average market capitalization across the [@Biotechnology] industry is $2.82B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACLX’s FA Score shows that 0 FA rating(s) are green whileBEAM’s FA Score has 0 green FA rating(s).

  • ACLX’s FA Score: 0 green, 5 red.
  • BEAM’s FA Score: 0 green, 5 red.
According to our system of comparison, BEAM is a better buy in the long-term than ACLX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACLX’s TA Score shows that 3 TA indicator(s) are bullish while BEAM’s TA Score has 5 bullish TA indicator(s).

  • ACLX’s TA Score: 3 bullish, 5 bearish.
  • BEAM’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, BEAM is a better buy in the short-term than ACLX.

Price Growth

ACLX (@Biotechnology) experienced а +1.71% price change this week, while BEAM (@Biotechnology) price change was +8.99% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.22%. For the same industry, the average monthly price growth was +14.28%, and the average quarterly price growth was +9.89%.

Reported Earning Dates

ACLX is expected to report earnings on Mar 20, 2025.

BEAM is expected to report earnings on Mar 04, 2025.

Industries' Descriptions

@Biotechnology (+4.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ACLX($4.65B) has a higher market cap than BEAM($2.01B). ACLX YTD gains are higher at: 55.748 vs. BEAM (-10.507). ACLX has higher annual earnings (EBITDA): -46.86M vs. BEAM (-162.88M). BEAM has more cash in the bank: 1.01B vs. ACLX (517M). ACLX has less debt than BEAM: ACLX (74.3M) vs BEAM (165M). BEAM has higher revenues than ACLX: BEAM (353M) vs ACLX (145M).
ACLXBEAMACLX / BEAM
Capitalization4.65B2.01B231%
EBITDA-46.86M-162.88M29%
Gain YTD55.748-10.507-531%
P/E RatioN/AN/A-
Revenue145M353M41%
Total Cash517M1.01B51%
Total Debt74.3M165M45%
TECHNICAL ANALYSIS
Technical Analysis
ACLXBEAM
RSI
ODDS (%)
Bearish Trend 2 days ago
84%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
81%
Momentum
ODDS (%)
Bearish Trend 2 days ago
71%
Bullish Trend 2 days ago
82%
MACD
ODDS (%)
Bearish Trend 2 days ago
73%
Bullish Trend 2 days ago
73%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
81%
Declines
ODDS (%)
Bearish Trend 6 days ago
75%
Bearish Trend 14 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
79%
Aroon
ODDS (%)
Bullish Trend 2 days ago
89%
Bearish Trend 2 days ago
85%
View a ticker or compare two or three
Ad is loading...
ACLX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
BEAM
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SETM18.120.12
+0.69%
Sprott Critical Materials ETF
LEMB36.880.21
+0.57%
iShares JP Morgan EM Local Ccy Bd ETF
MUNI52.110.18
+0.35%
PIMCO Intermediate Municipal Bd Actv ETF
DULL7.72-0.03
-0.45%
MicroSectors™ Gold -3X Inverse Lvrgd ETN
GMOM28.85-0.26
-0.88%
Cambria Global Momentum ETF

ACLX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACLX has been loosely correlated with CRSP. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if ACLX jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACLX
1D Price
Change %
ACLX100%
+0.31%
CRSP - ACLX
49%
Loosely correlated
-0.28%
BEAM - ACLX
47%
Loosely correlated
+6.24%
KYMR - ACLX
46%
Loosely correlated
+1.29%
ALLO - ACLX
45%
Loosely correlated
+10.29%
RCKT - ACLX
45%
Loosely correlated
-0.91%
More

BEAM and

Correlation & Price change

A.I.dvisor indicates that over the last year, BEAM has been closely correlated with CRSP. These tickers have moved in lockstep 74% of the time. This A.I.-generated data suggests there is a high statistical probability that if BEAM jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BEAM
1D Price
Change %
BEAM100%
+6.24%
CRSP - BEAM
74%
Closely correlated
-0.28%
NTLA - BEAM
68%
Closely correlated
+2.30%
EDIT - BEAM
65%
Loosely correlated
-1.03%
DNLI - BEAM
65%
Loosely correlated
+0.59%
PRME - BEAM
64%
Loosely correlated
-1.49%
More